FDA Inspection
Boehringer Ingelheim Pharma GmbH & Co. KGFDA Inspection 1208521 - Boehringer Ingelheim Pharma GmbH & Co. KG - October 07, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Boehringer Ingelheim Pharma GmbH & Co. KG, with an inspection on October 7, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 9d43c9ec-b673-4acd-9149-001abff90db2